The article you requested is
The Scourge of EPS: Have Atypical Antipsychotics Solved the Problem?
J Clin Psychiatry 2000;61(12):955-962
© Copyright 2016 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Treatment-emergent extrapyramidal symptoms (EPS) are frequent, distressing, and disabling complications of standard antipsychotics. They include, stated Professor Kasper in his introduction, akathisia, muscle spasms (dystonia), involuntary grimacing or chewing movements (dyskinesia), and symptoms resembling Parkinson’s disease (parkinsonism), e.g., tremor, rigidity, bradykinesia. All these types of movement disorder can manifest alone or in a mixed syndrome. Akathisia is a form of restlessness that can include both observed restlessness, manifesting as inability to sit still for any length of time, and a subtle sense of inner restlessness.